アブストラクト | This study was conducted to examine times to onset, incidence rates, and outcomes of nivolumab-induced lung adverse events (AEs), using the Japanese Adverse Drug Event Report database. We analysed data for the period between April 2004 and March 2021. Data on lung AEs were extracted, and relative risks of AEs were estimated using the reporting odds ratio. We analysed 5,273,115 reports and found 18,721 reports of nivolumab-related AEs, including 3084 lung AEs. Signals were detected for nine lung AEs: interstitial lung disease; pneumonitis; lung disorder; organising pneumonia; pleural effusion; pneumonia aspiration; pneumonia bacterial; radiation pneumonitis; and infectious pleural effusion. Among these, interstitial lung disease was the most frequently reported (68.7%) and included some fatal cases. A histogram of median times to onset showed AEs occurring from 34 to 79 days after the first dose, but some cases occurred even more than one year after starting administration. In conclusion, we focused on lung AEs caused by nivolumab as post-marketing AEs. Some cases could potentially involve serious outcomes, particularly in interstitial lung disease. Patients should be monitored for signs of the development of these AEs not only at the start of administration, but also over an extended time. |
ジャーナル名 | Scientific reports |
Pubmed追加日 | 2023/6/1 |
投稿者 | Kanbayashi, Yuko; Shimizu, Tadashi; Kojima, Asuka; Anzai, Miku; Kawai, Rika; Uchida, Mayako |
組織名 | Department of Education and Research Center for Clinical Pharmacy, Faculty of;Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara,;Takatsuki, Osaka, 569-1094, Japan. yuko.kambayashi@ompu.ac.jp.;School of Pharmacy, Hyogo Medical University, 1-3-6 Minatojima, Kobe, Hyogo,;650-8530, Japan.;Department of Education and Research Center for Pharmacy Practice, Faculty of;Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, 97-1,;Kodominamihokotate, Kyotanabe-shi, Kyoto, 610-0395, Japan. |
Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/37258564/ |